Clariane Past Earnings Performance
Past criteria checks 0/6
Clariane's earnings have been declining at an average annual rate of -36.2%, while the Healthcare industry saw earnings growing at 12.2% annually. Revenues have been growing at an average rate of 7.9% per year.
Key information
-36.2%
Earnings growth rate
-39.6%
EPS growth rate
| Healthcare Industry Growth | 13.4% |
| Revenue growth rate | 7.9% |
| Return on equity | -2.0% |
| Net Margin | -1.9% |
| Last Earnings Update | 31 Dec 2023 |
Recent past performance updates
Recent updates
Clariane (EPA:CLARI) Takes On Some Risk With Its Use Of Debt
Apr 28
Is It Too Late To Consider Buying Clariane SE (EPA:CLARI)?
Dec 06These 4 Measures Indicate That Clariane (EPA:CLARI) Is Using Debt Extensively
Oct 31Calculating The Fair Value Of Clariane SE (EPA:CLARI)
Sep 21What Is Clariane SE's (EPA:CLARI) Share Price Doing?
Jul 29At €6.98, Is It Time To Put Korian (EPA:KORI) On Your Watch List?
Apr 04These 4 Measures Indicate That Korian (EPA:KORI) Is Using Debt Extensively
Mar 16A Look At The Fair Value Of Korian (EPA:KORI)
Jan 16Should You Think About Buying Korian (EPA:KORI) Now?
Dec 26Does Korian (EPA:KORI) Have A Healthy Balance Sheet?
Dec 01Is There Now An Opportunity In Korian (EPA:KORI)?
Sep 26Is Korian (EPA:KORI) A Risky Investment?
Aug 31Why Korian (EPA:KORI) Could Be Worth Watching
Jun 14We Think Korian (EPA:KORI) Is Taking Some Risk With Its Debt
Mar 30Korian (EPA:KORI) Has A Somewhat Strained Balance Sheet
Dec 24Korian (EPA:KORI) Seems To Be Using A Lot Of Debt
Sep 25Why Korian (EPA:KORI) Could Be Worth Watching
Jul 15Does Korian (EPA:KORI) Have A Healthy Balance Sheet?
Jun 18Are Investors Undervaluing Korian (EPA:KORI) By 42%?
May 05These 4 Measures Indicate That Korian (EPA:KORI) Is Using Debt Extensively
Mar 18Korian (EPA:KORI) Just Released Its Yearly Earnings: Here's What Analysts Think
Feb 28We Wouldn't Rely On Korian's (EPA:KORI) Statutory Earnings As A Guide
Feb 02
If You Had Bought Korian's (EPA:KORI) Shares A Year Ago You Would Be Down 23%
Jan 13Is There An Opportunity With Korian's (EPA:KORI) 46% Undervaluation?
Dec 28What Does Korian's (EPA:KORI) Share Price Indicate?
Dec 15Revenue & Expenses BreakdownBeta
How Clariane makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
| Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
|---|---|---|---|---|
| 31 Dec 23 | 4,996 | -92 | 545 | 0 |
| 30 Sep 23 | 4,865 | -32 | 527 | 0 |
| 30 Jun 23 | 4,735 | 28 | 509 | 0 |
| 31 Mar 23 | 4,587 | 32 | 483 | 0 |
| 31 Dec 22 | 4,438 | 36 | 458 | 0 |
| 30 Jun 22 | 4,288 | 85 | 439 | 0 |
| 31 Mar 22 | 4,212 | 92 | 434 | 0 |
| 31 Dec 21 | 4,137 | 100 | 430 | 0 |
| 30 Sep 21 | 4,047 | 76 | 404 | 0 |
| 30 Jun 21 | 3,941 | 60 | 425 | 0 |
| 31 Mar 21 | 3,857 | 50 | 431 | 0 |
| 31 Dec 20 | 3,773 | 39 | 437 | 0 |
| 30 Sep 20 | 3,728 | 57 | 446 | 0 |
| 30 Jun 20 | 3,683 | 74 | 456 | 0 |
| 31 Mar 20 | 3,648 | 94 | 452 | 0 |
| 31 Dec 19 | 3,613 | 115 | 449 | 0 |
| 30 Sep 19 | 3,542 | 117 | 528 | 0 |
| 30 Jun 19 | 3,471 | 119 | 607 | 0 |
| 31 Mar 19 | 3,404 | 121 | 686 | 0 |
| 31 Dec 18 | 3,336 | 123 | 765 | 0 |
| 30 Sep 18 | 3,280 | 152 | 755 | 0 |
| 30 Jun 18 | 3,224 | 180 | 744 | 0 |
| 31 Mar 18 | 3,177 | 172 | 739 | 0 |
| 31 Dec 17 | 3,131 | 163 | 735 | 0 |
| 30 Sep 17 | 3,091 | 150 | 736 | 0 |
| 30 Jun 17 | 3,052 | 137 | 738 | 0 |
| 31 Mar 17 | 3,017 | 134 | 733 | 0 |
| 31 Dec 16 | 2,981 | 131 | 728 | 0 |
| 30 Sep 16 | 2,880 | 87 | 706 | 0 |
| 30 Jun 16 | 2,779 | 42 | 684 | 0 |
| 31 Mar 16 | 2,676 | 50 | 674 | 0 |
| 31 Dec 15 | 2,573 | 59 | 664 | 0 |
| 30 Sep 15 | 2,553 | 77 | 664 | 0 |
| 30 Jun 15 | 2,533 | 95 | 664 | 0 |
| 31 Mar 15 | 2,378 | 78 | 631 | 0 |
| 31 Dec 14 | 2,222 | 61 | 597 | 0 |
| 30 Sep 14 | 1,938 | 44 | 526 | 0 |
| 30 Jun 14 | 1,654 | 27 | 455 | 0 |
| 31 Mar 14 | 1,505 | 28 | 423 | 0 |
| 31 Dec 13 | 1,356 | 29 | 391 | 0 |
| 30 Sep 13 | 1,286 | 29 | 378 | 0 |
| 30 Jun 13 | 1,216 | 29 | 364 | 0 |
Quality Earnings: CLARI is currently unprofitable.
Growing Profit Margin: CLARI is currently unprofitable.
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: CLARI is unprofitable, and losses have increased over the past 5 years at a rate of 36.2% per year.
Accelerating Growth: Unable to compare CLARI's earnings growth over the past year to its 5-year average as it is currently unprofitable
Earnings vs Industry: CLARI is unprofitable, making it difficult to compare its past year earnings growth to the Healthcare industry (2%).
Return on Equity
High ROE: CLARI has a negative Return on Equity (-2.04%), as it is currently unprofitable.